Home
|
Contact us
|
Disclaimer
Corporate Overview
Management
Board of Directors
Contact us
Business Ethics
Product pipeline
Alzheimer's disease
Bipolar disorder
Diabetes and obesity
Inflammatory diseases
Current partnership
In/Out-licensing opportunity
Agitation/aggression in AD
Bipolar disorder
Diabetes and obesity
Cognition/function in AD
Stock quote
Financial reports
Analyst coverage
Request information
Subscribe to e-mail alert
Press release 2013
Press release archive
Webcast and presentation
INVESTOR relations
Stock Quotes
Financial Reports
Analyst Coverage
Insider Trading (SEDI)
Request Information
E-mail Alert
SEDAR filings
EDGAR filings
Annual Reports
2012
2011
2010
2009
Financial Reports
Fiscal Year
First Quarter
Second Quarter
Third Quarter
Year-End
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
Auditor
PricewaterhouseCoopers LLP
Mississauga, Ontario, Canada
© 2012 Transition Therapeutics Inc.